Exelixis, Inc. (EXEL) Discusses Strategic Approach to Building Next-Generation Oncology Franchises at R&D Day Transcript [Seeking Alpha]
Exelixis, Inc. (EXEL)
Last exelixis, inc. earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-mediaresources
Company Research
Source: Seeking Alpha
Company Participants Susan Hubbard - Executive Vice President of Public Affairs & Investor Relations Michael Morrissey - CEO, President & Director P. Haley - Executive Vice President of Commercial Dana Aftab - Executive Vice President of Research & Development Conference Call Participants Toni Choueiri Anwaar Saeed Jennifer Chan Conversation Operator Welcome to the Exelixis virtual event. Please welcome Executive Vice President of Public Affairs and Investor Relations, Susan Hubbard. Susan Hubbard Executive Vice President of Public Affairs & Investor Relations Welcome, everyone, to the Exelixis 2025 R&D Day, building next-generation oncology franchises. We very much appreciate you taking time to join us today. As you can see, we have a very busy agenda and are delighted to be joined during the disease focus areas by 3 guest speakers, Dr. Choueiri, Dr. Saeed and Dr. Chan. But let me just start by saying that during the course of this presentation, we will b
Show less
Read more
Impact Snapshot
Event Time:
EXEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EXEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EXEL alerts
High impacting Exelixis, Inc. news events
Weekly update
A roundup of the hottest topics
EXEL
News
- Exelixis to Webcast Virtual 2025 Research & Development (R&D) Day on Wednesday, December 10, 2025Business Wire
- Exelixis (NASDAQ:EXEL) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.MarketBeat
- Exelixis, Inc. (EXEL) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript [Seeking Alpha]Seeking Alpha
- Company News for Nov 6, 2025 [Yahoo! Finance]Yahoo! Finance
- Exelixis: The STELLAR Win Is A Mixed Bag, But Things Look Positive Still [Seeking Alpha]Seeking Alpha
EXEL
Earnings
- 11/4/25 - Beat
EXEL
Sec Filings
- 12/12/25 - Form 144
- 12/5/25 - Form 4
- 11/26/25 - Form 4
- EXEL's page on the SEC website